Undergraduate Thesis Or Project
 

Superior Anti-tumor Activity Exhibited From a Gemcitabine Prodrug Incorporated into Lecithin-Based Nanoparticles

Pubblico Deposited

Contenuto scaricabile

Scarica il pdf
https://ir.library.oregonstate.edu/concern/undergraduate_thesis_or_projects/ht24wm403

Descriptions

Attribute NameValues
Creator
Abstract
  • Cancer is class of diseases that has great diversity and unfortunately is one of the leading causes of death in the United States. Chemotherapy remains an important cancer treatment modality, and superior chemotherapeutic drugs are constantly being sought. Gemcitabine is an anti-tumor chemotherapeutic drug and it is the first line of defense in treating pancreatic cancer, as well as, used in combination therapy for non-small cell lung, ovarian, and metastatic breast cancers. Patients with cancer, specifically pancreatic carcinoma, have a high mortality rate which highlights the poor anti-tumor activity of gemcitabine. The anti-tumor activity of gemcitabine shows needed improvement due to its short half-life and low specificity in patients. The objective of this study is to utilize lecithin-based nanoparticles (NP) as a delivery system for a lipophilic gemcitabine prodrug. From this current study, a maximum drug concentration of 5 mg/ml was achieved into nanoparticles, thereby improving anticancer activity of gemcitabine. Keywords: Gemcitabine, nanoparticles, chemotherapy
License
Resource Type
Date Available
Date Issued
Degree Level
Degree Name
Degree Field
Degree Grantor
Commencement Year
Advisor
Committee Member
Non-Academic Affiliation
Dichiarazione dei diritti
Publisher
Peer Reviewed
Language
Replaces

Le relazioni

Parents:
In Collection:

Elementi

Thumbnail Titolo Data caricata Visibilità Azioni
file details Michael Sandoval BRR Thesis.pdf 07/26/2017 Pubblico
file details Thesis Seminar Michael Sandoval.ppt 07/26/2017 Pubblico
file details Poster Presentation Michael Sandoval.pdf 07/26/2017 Pubblico